Fundació Privada Institut d'Investigació Oncològica de Vall Hebron
发明人:
申请号：
EP19172033.3
公开号：
EP3545966A1
申请日:
2014.05.07
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The invention relates to a Myc dominant negative mutant, called Omomyc, for use in medicine and for use in the prevention and/or treatment of cancer. The invention also refers to a fusion protein comprising Omomyc and pharmaceutical composition thereof and their use in medicine and, in particular, for treatment of cancer.
